Issue link: http://www.e-digitaleditions.com/i/898603
Tablets & Capsules November 2017 21 Using static image analysis to size crystalline particles. Patrick O'Hagan, Kerry Hasapidis, Vincent Chapeau, and Christian Godino. May 2008, p. 30. Powder flow Assessing how the physical properties and enhanced pow- der flow of HMPC translate to process control during direct compression of matrix tablets. True L. Rogers, Kathryn O. Hewlett, Jörg Theuerkauf, Karen M. Balwinski, and Madhusudhan Kodam. October 2014, p. 14. Fumed silica improves powder flow. Elizabeth Sims and Michael Famiglietti. Eye on Excipients, April 2016, p. 47. Identifying and controlling segregation in tablet press feed systems. Kerry Johanson. May 2017, p. 18. Measuring bulk density: Advantages of a shear cell. Vinnie Hebert. October 2013, p. 31. A novel MCC for reducing segregation in direct-to- press blends. Yosuke Honda, Syozo Kaneyama, and Stephen Turner. July 2017, p. 24. Preventive medicine: Keys to avoiding powder flow problems. Thomas Baxter. March 2007, p. 36. Relating flow properties to process behavior in tablet presses and capsule filling machines. Kerry Johanson. May 2014, p. 28. Separation anxiety: Addressing variations in content uni- formity data in compression processes. Thomas Baxter and James Prescott. March 2010, p. 22. Testing powder flowability. Robert G. McGregor. March 2011, p. 20. Tracking bulk density to maximize tablet production. Vinnie Hebert. March 2016, p. 27. Using fundamental powder properties to optimize flowa- bility. Greg Mehos, Mike Eggleston, Tristan Trautman, Matthew Freeman, and Nicole Stevens-Murphy. October 2017, p. 11. When powders flow like water: Addressing two-phase flow effects in tablet press feed systems. Thomas Baxter. March 2009, p. 26. Regulation, standards, and guidance ANSI/ASHRAE Standard 199: A new tool for specify- ing pharmaceutical dust collection equipment. Rick Kreczmer and David Steil. March 2017, p. 35. Accounting for differences in TSM and EU tooling. Rich Kirk. July 2010, p. 34. Assessing an analytical method for the dissolution profile of an extended-release tablet in accordance with QbD. Maria Maeso Puertollano, Tim Cartwright, Mike Aylott, and Nicola Kaye. January 2009, p. 30. Assessing risk and controlling exposure to potent com- pounds during pharmaceutical packaging. John P. Farris. May 2010, p. 8. Blister technology adapts to meet regulatory and market demands. Matthew Knopp. May 2012, p. 14. The buck stops where? Clarifying responsibility under qual- ity agreements. Justin Prochnow. October 2015, p. 32B. Can PAT "build in" quality? Yashwant Pathak. Back Page, September 2007, p. 72. Chitosan as a pharmaceutical excipient? John McCarty. Eye on Excipients, September 2013, p. 51. Clearing the regulatory hurdles to bring a supplement product to market. Justin J. Prochnow. July 2010, p. 32C. Combine the TSM and ISO tooling standards. Dale Natoli. Back Page, October 2010, p. 64. Compactability testing of excipients, part 1. Metin Çelik. Eye on Excipients, April 2009, p. 42. Compactability testing of excipients, part 2. Metin Çelik. Eye on Excipients, May 2009, p. 33. Compliance challenges facing the nutraceutical and dietary-supplement industries. Joy A. Joseph. March 2009, p. 32C. Containment of high-potency drug products: Outsourcing and other challenges. Emily Nystrom. March 2010, p. 8. Contracting with the dietary supplement cGMPs in mind. Paul M. Hyman and Bryon F. Powell. September 2009, p. 32C. Creating compliant labels for dietary supplements in Canada. Peter Wojewnik. September 2010, p. 32C. Everyone needs a war room. Carol Brennon. Back Page, October 2008, p. 96. Differences Down-Under: Australian labels for comple- mentary medicines vs. US labels for dietary supplements. Robert Forbes. September 2010, p. 32D. Dispelling solid dosage misinterpretations of the USP- NF. Susan J. Schniepp. October 2009, p. 14. Drug product recalls: An overview of the process. Edward J. Bauer. May 2012, p. 8. Effect of sampling methods on vitamin D blending uni- formity. Wenming Zeng, Dan Wang, and Doug Roper. October 2016, p. 17. Elemental impurities. John McCarty. Eye on Excipients, March 2013, p. 39. Elemental impurities limits. John A. McCarty. Eye on Excipients, May 2012, p. 33. Embracing QbD and PAT in nutraceutical production. Misty Muscarella, Charles Preuss, Y.V. Pathak, and Adnan Sabir. October 2011, p. 18. Excipient quality and QbD. Alen Guy. Eye on Excipients, January 2012, p. 39. Excipient selection: Practical advice on using SUPAC. Metin Çelik. July 2008, p. 15. Excipients in the news. Matthew Knopp. Back Page, July 2013, p. 48. FDA draft Guidance on new dietary ingredients: Do you need to file? Amy Scanlin. July 2017, p. 32B. i n d e x t o a r t i c l e s